Navigation Links
New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
Date:11/21/2008

ride with or without metformin, were also conducted. In addition to a stable dose of metformin, pioglitazone, glimepiride, or glimepiride and metformin, patients whose diabetes was not adequately controlled were given either JANUVIA 100mg daily or placebo. The adverse reactions, reported regardless of investigator assessment of causality in >=5% of patients treated with JANUVIA 100mg daily as monotherapy, JANUVIA in combination with pioglitazone, or JANUVIA in combination with glimepiride, with or without metformin, and more commonly than in patients treated with placebo, are shown in Table1.
Table 1

Placebo-Controlled Clinical Studies of JANUVIA Monotherapy or Add-on Combination Therapy with Pioglitazone or Glimepiride +/- Metformin: Adverse Reactions Reported in >=5% of Patients and More Commonly than in Patients Given Placebo, Regardless of Investigator Assessment of Causality†

Number of Patients (%) Monotherapy JANUVIA 100 mg Placebo N = 443 N = 363 Nasopharyngitis 23 (5.2) 12 (3.3) Combination with Pioglitazone JANUVIA 100 mg + Pioglitazone

Placebo + Pioglitazone

N = 175 N = 178 Upper Respiratory Tract Infection 11 (6.3) 6 (3.4) Headache 9 (5.1) 7 (3.9) Combination with Glimepiride (+/- Metformin) JANUVIA 100 mg + Glimepiride

(+/- Metformin)

Placebo + Glimepiride

(+/- Metformin)

N = 222 N = 219 Hypoglycemia 27 (12.2) 4 (1.8) Nasopharyngitis 14 (6.3) 10 (4.6) Headache 13 (5.9) 5 (2.3) † Intent to treat population

  • the study of patients receiving JANUVIA as add-on combination therapy with metformin, there were no adverse reactions reported regardless of investigator assessment of causality in e5% of patients and more commonly than in patients given placebo.


    Source: PRWeb
    Copyright©2008 Vocus, Inc.
    All rights reserved  

    3

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

    Related medicine news :

    1. STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses
    2. Landmark study defines benefits of early HIV testing and treatment for infected infants
    3. Study identifies causes of bone loss in breast cancer survivors
    4. New Study by BioTrends Highlights Practice Management Shifts Among Canadian Nephrologists
    5. Study Suggests Need for More Aggressive Outpatient Monitoring of Patients Hearts When Cause of Stroke is Unclear
    6. Rutgers researchers study cites media violence as critical risk factor for aggression
    7. Brigham and Womens Researchers Partner with Vocantas to use CallAssure in Clinical Research Study
    8. Analyst Available to Comment on New JUPITER Study That Shows AstraZenecas Crestor Significantly Reduces CV Risk
    9. New Study Finds CO2 Ablative Fractional Resurfacing Safe And Effective For Deep Acne Scarring
    10. Study investigates Gore-tex-type device to stop strokes and mini-strokes
    11. The smart way to study
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Related Image:
     New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 
    New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
    Breaking Medicine Technology:New Research Shows a Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-Dwelling Adults 2Van Andel Institute Cuts Ribbon on $178 Million Expansion 2Van Andel Institute Cuts Ribbon on $178 Million Expansion 3Van Andel Institute Cuts Ribbon on $178 Million Expansion 4Nplate(R) Data From MDS Studies Presented at ASH 2Nplate(R) Data From MDS Studies Presented at ASH 3Nplate(R) Data From MDS Studies Presented at ASH 4Nplate(R) Data From MDS Studies Presented at ASH 5Nplate(R) Data From MDS Studies Presented at ASH 6Nplate(R) Data From MDS Studies Presented at ASH 7Nplate(R) Data From MDS Studies Presented at ASH 8Nplate(R) Data From MDS Studies Presented at ASH 9Nplate(R) Data From MDS Studies Presented at ASH 10Star Scientific Breaks New Ground Plans FDA Filing for Approval of First Modified Risk Tobacco Product 3B Nominates Curtis Wright MD MPH for FDA Ad 57981 1Star Scientific Breaks New Ground Plans FDA Filing for Approval of First Modified Risk Tobacco Product 3B Nominates Curtis Wright MD MPH for FDA Ad 57981 2Star Scientific Breaks New Ground Plans FDA Filing for Approval of First Modified Risk Tobacco Product 3B Nominates Curtis Wright MD MPH for FDA Ad 57981 3Star Scientific Breaks New Ground Plans FDA Filing for Approval of First Modified Risk Tobacco Product 3B Nominates Curtis Wright MD MPH for FDA Ad 57981 4Star Scientific Breaks New Ground Plans FDA Filing for Approval of First Modified Risk Tobacco Product 3B Nominates Curtis Wright MD MPH for FDA Ad 57981 5Bon Secours Richmond Named A Top Ten 2009 Working Mother 100 Best Company 57977 1Bon Secours Richmond Named A Top Ten 2009 Working Mother 100 Best Company 57977 2Bon Secours Richmond Named A Top Ten 2009 Working Mother 100 Best Company 57977 3Bon Secours Richmond Named A Top Ten 2009 Working Mother 100 Best Company 57977 4Healthcare Reform 3A Driving Healthcare Costs Down Through Improved Efficiency and Quality of Care 57974 1Healthcare Reform 3A Driving Healthcare Costs Down Through Improved Efficiency and Quality of Care 57974 2Healthcare Reform 3A Driving Healthcare Costs Down Through Improved Efficiency and Quality of Care 57974 3